212 related articles for article (PubMed ID: 35198080)
1. Radiotracer stereochemistry affects substrate affinity and kinetics for improved imaging of system x
Greenwood HE; Edwards R; Koglin N; Berndt M; Baark F; Kim J; Firth G; Khalil E; Mueller A; Witney TH
Theranostics; 2022; 12(4):1921-1936. PubMed ID: 35198080
[TBL] [Abstract][Full Text] [Related]
2. Comparative Evaluation of [
Colovic M; Yang H; Southcott L; Merkens H; Colpo N; Bénard F; Schaffer P
J Nucl Med; 2023 Aug; 64(8):1314-1321. PubMed ID: 37116917
[TBL] [Abstract][Full Text] [Related]
3. [
Hoehne A; James ML; Alam IS; Ronald JA; Schneider B; D'Souza A; Witney TH; Andrews LE; Cropper HC; Behera D; Gowrishankar G; Ding Z; Wyss-Coray T; Chin FT; Biswal S; Gambhir SS
J Neuroinflammation; 2018 Feb; 15(1):55. PubMed ID: 29471880
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Tumor Redox Status through (
McCormick PN; Greenwood HE; Glaser M; Maddocks ODK; Gendron T; Sander K; Gowrishankar G; Hoehne A; Zhang T; Shuhendler AJ; Lewis DY; Berndt M; Koglin N; Lythgoe MF; Gambhir SS; Årstad E; Witney TH
Cancer Res; 2019 Feb; 79(4):853-863. PubMed ID: 30401715
[TBL] [Abstract][Full Text] [Related]
5. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
6. Imaging the Tumor Antioxidant Response with [
Timmermand OV; Witney TH
Methods Mol Biol; 2024; 2729():233-249. PubMed ID: 38006500
[TBL] [Abstract][Full Text] [Related]
7. Measurement of Tumor Antioxidant Capacity and Prediction of Chemotherapy Resistance in Preclinical Models of Ovarian Cancer by Positron Emission Tomography.
Greenwood HE; McCormick PN; Gendron T; Glaser M; Pereira R; Maddocks ODK; Sander K; Zhang T; Koglin N; Lythgoe MF; Årstad E; Hochhauser D; Witney TH
Clin Cancer Res; 2019 Apr; 25(8):2471-2482. PubMed ID: 30651275
[TBL] [Abstract][Full Text] [Related]
8.
Wardak M; Sonni I; Fan AP; Minamimoto R; Jamali M; Hatami N; Zaharchuk G; Fischbein N; Nagpal S; Li G; Koglin N; Berndt M; Bullich S; Stephens AW; Dinkelborg LM; Abel T; Manning HC; Rosenberg J; Chin FT; Gambhir SS; Mittra ES
Radiology; 2022 Jun; 303(3):620-631. PubMed ID: 35191738
[TBL] [Abstract][Full Text] [Related]
9. (4S)-4-(3-18F-fluoropropyl)-L-glutamate for imaging of xC transporter activity in hepatocellular carcinoma using PET: preclinical and exploratory clinical studies.
Baek S; Mueller A; Lim YS; Lee HC; Lee YJ; Gong G; Kim JS; Ryu JS; Oh SJ; Lee SJ; Bacher-Stier C; Fels L; Koglin N; Schatz CA; Dinkelborg LM; Moon DH
J Nucl Med; 2013 Jan; 54(1):117-23. PubMed ID: 23232273
[TBL] [Abstract][Full Text] [Related]
10. Functional imaging of oxidative stress with a novel PET imaging agent, 18F-5-fluoro-L-aminosuberic acid.
Webster JM; Morton CA; Johnson BF; Yang H; Rishel MJ; Lee BD; Miao Q; Pabba C; Yapp DT; Schaffer P
J Nucl Med; 2014 Apr; 55(4):657-64. PubMed ID: 24578242
[TBL] [Abstract][Full Text] [Related]
11. Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES; Koglin N; Mosci C; Kumar M; Hoehne A; Keu KV; Iagaru AH; Mueller A; Berndt M; Bullich S; Friebe M; Schmitt-Willich H; Gekeler V; Fels LM; Bacher-Stier C; Moon DH; Chin FT; Stephens AW; Dinkelborg LM; Gambhir SS
PLoS One; 2016; 11(2):e0148628. PubMed ID: 26890637
[TBL] [Abstract][Full Text] [Related]
12. The Characterization of
Beinat C; Gowrishankar G; Shen B; Alam IS; Robinson E; Haywood T; Patel CB; Azevedo EC; Castillo JB; Ilovich O; Koglin N; Schmitt-Willich H; Berndt M; Mueller A; Zerna M; Srinivasan A; Gambhir SS
J Nucl Med; 2019 Dec; 60(12):1812-1817. PubMed ID: 31171595
[TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
14. Utility of [
Kavanaugh G; Williams J; Morris AS; Nickels ML; Walker R; Koglin N; Stephens AW; Washington MK; Geevarghese SK; Liu Q; Ayers D; Shyr Y; Manning HC
Mol Imaging Biol; 2016 Dec; 18(6):924-934. PubMed ID: 27677886
[TBL] [Abstract][Full Text] [Related]
15. Robust and Facile Automated Radiosynthesis of [
Edwards R; Greenwood HE; McRobbie G; Khan I; Witney TH
Mol Imaging Biol; 2021 Dec; 23(6):854-864. PubMed ID: 34013395
[TBL] [Abstract][Full Text] [Related]
16. Prospective comparison of (4S)-4-(3-
Cheng MF; Huang YY; Ho BY; Kuo TC; Hsin LW; Shiue CY; Kuo HC; Jeng YM; Yen RF; Tien YW
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):810-820. PubMed ID: 30635754
[TBL] [Abstract][Full Text] [Related]
17. Exploratory clinical trial of (4S)-4-(3-[18F]fluoropropyl)-L-glutamate for imaging xC- transporter using positron emission tomography in patients with non-small cell lung or breast cancer.
Baek S; Choi CM; Ahn SH; Lee JW; Gong G; Ryu JS; Oh SJ; Bacher-Stier C; Fels L; Koglin N; Hultsch C; Schatz CA; Dinkelborg LM; Mittra ES; Gambhir SS; Moon DH
Clin Cancer Res; 2012 Oct; 18(19):5427-37. PubMed ID: 22893629
[TBL] [Abstract][Full Text] [Related]
18. PET Imaging of System x
Seo M; Kim Y; Ye BD; Park SH; Kim SY; Jung JH; Hwang SW; Chae SY; Lee DY; Lee SJ; Oh SJ; Kim J; Kim JY; Na SJ; Kim M; Kim SY; Koglin N; Stephens AW; Kweon MN; Moon DH
J Nucl Med; 2022 Oct; 63(10):1586-1591. PubMed ID: 35086893
[TBL] [Abstract][Full Text] [Related]
19. Initial evaluation of (4S)-4-(3-[
Park SY; Mosci C; Kumar M; Wardak M; Koglin N; Bullich S; Mueller A; Berndt M; Stephens AW; Chin FT; Gambhir SS; Mittra ES
EJNMMI Res; 2020 Aug; 10(1):100. PubMed ID: 32857284
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
